Autolus Therapeutics Net Income Over Time
| AUTL Stock | USD 1.40 0.02 1.45% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Autolus Therapeutics Performance and Autolus Therapeutics Correlation. Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Autolus Therapeutics. If investors know Autolus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Autolus Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.83) | Revenue Per Share | Quarterly Revenue Growth (0.11) | Return On Assets | Return On Equity |
The market value of Autolus Therapeutics is measured differently than its book value, which is the value of Autolus that is recorded on the company's balance sheet. Investors also form their own opinion of Autolus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Autolus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Autolus Therapeutics' market value can be influenced by many factors that don't directly affect Autolus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Autolus Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Autolus Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Autolus Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Net Income Analysis
Compare Autolus Therapeutics and related stocks such as Kaleido Biosciences, Innovation1 Biotech, and Xeno Transplants Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XENO | (46.7 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (230.7 K) | (242.3 K) |
| SYVC | (2.9 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (3.6 M) | (3.8 M) |
Autolus Therapeutics and related stocks such as Kaleido Biosciences, Innovation1 Biotech, and Xeno Transplants Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Autolus Therapeutics financial statement analysis. It represents the amount of money remaining after all of Autolus Therapeutics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Autolus Therapeutics | AUTL |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | The Mediaworks, London, |
| Exchange | NASDAQ Exchange |
USD 1.4
Check out Autolus Therapeutics Performance and Autolus Therapeutics Correlation. For more information on how to buy Autolus Stock please use our How to buy in Autolus Stock guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Autolus Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.